See more : Trimble Inc. (TRMB) Income Statement Analysis – Financial Results
Complete financial analysis of Mesa Laboratories, Inc. (MLAB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mesa Laboratories, Inc., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
You may be interested
- Nabriva Therapeutics plc (NBRVF) Income Statement Analysis – Financial Results
- Prima Plastics Limited (PRIMAPLA.BO) Income Statement Analysis – Financial Results
- Plasto-Cargal Group Ltd (PLCR.TA) Income Statement Analysis – Financial Results
- Cashbox Partyworld Co., Ltd. (8359.TWO) Income Statement Analysis – Financial Results
- Green Energy Enterprises, Inc. (GYOG) Income Statement Analysis – Financial Results
Mesa Laboratories, Inc. (MLAB)
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 216.19M | 219.08M | 184.34M | 133.94M | 117.69M | 103.14M | 96.18M | 93.67M | 84.66M | 71.33M | 52.72M | 46.44M | 39.62M | 32.83M | 21.93M | 21.54M | 19.56M | 17.24M | 11.58M | 10.04M | 9.13M | 9.08M | 9.04M | 9.10M | 8.66M | 8.10M | 7.90M | 7.80M | 8.10M | 6.60M | 6.20M | 4.40M | 3.80M | 3.50M | 2.80M | 1.10M | 1.00M |
| Cost of Revenue | 82.94M | 85.39M | 75.25M | 46.92M | 52.75M | 42.22M | 41.56M | 40.43M | 33.25M | 27.94M | 21.04M | 17.57M | 16.11M | 13.26M | 8.74M | 7.72M | 6.70M | 6.35M | 4.15M | 3.72M | 3.43M | 3.40M | 3.65M | 3.07M | 2.80M | 2.40M | 2.50M | 2.70M | 2.80M | 2.20M | 2.10M | 1.40M | 1.20M | 1.20M | 1.20M | 400.00K | 400.00K |
| Gross Profit | 133.25M | 133.69M | 109.09M | 87.01M | 64.93M | 60.92M | 54.62M | 53.24M | 51.41M | 43.39M | 31.69M | 28.86M | 23.51M | 19.57M | 13.19M | 13.82M | 12.86M | 10.90M | 7.44M | 6.32M | 5.70M | 5.68M | 5.39M | 6.03M | 5.85M | 5.70M | 5.40M | 5.10M | 5.30M | 4.40M | 4.10M | 3.00M | 2.60M | 2.30M | 1.60M | 700.00K | 600.00K |
| Gross Profit Ratio | 61.64% | 61.02% | 59.18% | 64.97% | 55.17% | 59.06% | 56.79% | 56.84% | 60.73% | 60.83% | 60.10% | 62.16% | 59.35% | 59.61% | 60.17% | 64.16% | 65.74% | 63.19% | 64.21% | 62.94% | 62.44% | 62.59% | 59.61% | 66.30% | 67.62% | 70.37% | 68.35% | 65.38% | 65.43% | 66.67% | 66.13% | 68.18% | 68.42% | 65.71% | 57.14% | 63.64% | 60.00% |
| Research & Development | 19.30M | 20.49M | 15.77M | 10.39M | 6.36M | 3.51M | 3.54M | 4.16M | 3.97M | 3.29M | 2.32M | 2.01M | 1.36M | 1.44M | 669.00K | 636.00K | 532.00K | 392.00K | 358.00K | 358.00K | 332.00K | 259.97K | 289.94K | 308.17K | 281.65K | 200.00K | 300.00K | 300.00K | 300.00K | 400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 72.87M | 72.44M | 60.31M | 45.70M | 37.83M | 31.30M | 26.26M | 22.81M | 23.62M | 17.06M | 11.46M | 9.12M | 5.42M | 4.58M | 2.54M | 2.52M | 5.27M | 4.84M | 2.97M | 2.49M | 2.12M | 2.24M | 2.16M | 2.40M | 2.39M | 2.20M | 2.10M | 2.10M | 2.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 38.63M | 37.44M | 28.31M | 18.48M | 12.91M | 8.26M | 8.82M | 9.96M | 7.50M | 7.18M | 6.12M | 4.63M | 3.91M | 3.69M | 2.62M | 3.05M | 2.85B | 2.77B | 1.88B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 111.49M | 109.88M | 88.62M | 64.18M | 50.74M | 39.56M | 35.08M | 32.77M | 31.12M | 24.23M | 17.58M | 13.75M | 9.33M | 8.26M | 5.16M | 5.57M | 5.27M | 4.84M | 2.97M | 2.49M | 2.12M | 2.24M | 2.16M | 2.40M | 2.39M | 2.20M | 2.10M | 2.10M | 2.30M | 1.80M | 2.30M | 1.60M | 1.30M | 1.20M | 1.00M | 600.00K | 600.00K |
| Other Expenses | 274.53M | -3.71M | -1.13M | 91.00K | 50.00K | -1.16M | -1.88M | -2.02M | -768.00K | -517.00K | 1.32M | -126.00K | 350.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 332.59K | 200.00K | 200.00K | 200.00K | 300.00K | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K | 100.00K | 0.00 | 0.00 |
| Operating Expenses | 406.55M | 130.37M | 104.39M | 74.66M | 57.14M | 43.06M | 38.62M | 36.93M | 35.09M | 27.53M | 19.90M | 15.76M | 10.68M | 9.70M | 5.83M | 6.21M | 5.80M | 5.24M | 3.33M | 2.85M | 2.45M | 2.50M | 2.45M | 2.71M | 3.01M | 2.60M | 2.60M | 2.60M | 2.90M | 2.50M | 2.50M | 1.70M | 1.40M | 1.40M | 1.10M | 600.00K | 600.00K |
| Cost & Expenses | 488.26M | 215.76M | 179.63M | 121.58M | 109.90M | 85.28M | 80.18M | 77.35M | 68.34M | 55.47M | 40.94M | 33.33M | 26.79M | 22.96M | 14.56M | 13.93M | 12.50M | 11.58M | 7.47M | 6.57M | 5.88M | 5.90M | 6.10M | 5.77M | 5.81M | 5.00M | 5.10M | 5.30M | 5.70M | 4.70M | 4.60M | 3.10M | 2.60M | 2.60M | 2.30M | 1.00M | 1.00M |
| Interest Income | 0.00 | 4.77M | 3.89M | 107.00K | 960.00K | 1.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 86.00K | 195.00M | 130.00M | 193.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.70M | 3.71M | 3.89M | 8.02M | 5.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 31.57M | 33.13M | 25.07M | 17.47M | 12.87M | 9.47M | 9.47M | 8.74M | 7.17M | 5.66M | 3.84M | 3.43M | 2.22M | 1.84M | 786.00K | 788.00K | 742.00K | 669.00K | 93.00K | 90.00K | 97.00K | 115.35K | 115.09K | 521.69K | 332.59K | 200.00K | 200.00K | 200.00K | 300.00K | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K | 100.00K | 0.00 | 0.00 |
| EBITDA | -238.38M | 36.45M | 29.77M | 12.36M | 8.09M | 18.09M | 9.77M | 25.05M | 23.50M | 21.52M | 15.63M | 16.54M | 14.55M | 11.71M | 8.15M | 8.40M | 7.80M | 6.33M | 4.20M | 3.57M | 3.35M | 3.30M | 3.06M | 3.85M | 3.18M | 3.30M | 3.20M | 2.70M | 2.70M | 2.20M | 1.80M | 1.40M | 1.30M | 1.10M | 600.00K | 100.00K | 0.00 |
| EBITDA Ratio | -110.26% | 1.52% | 2.55% | 9.23% | 6.87% | 34.28% | 31.01% | 17.42% | 19.28% | 22.24% | 22.35% | 28.22% | 39.22% | 36.01% | 33.76% | 38.99% | 39.90% | 36.70% | 36.29% | 35.50% | 36.66% | 36.36% | 33.80% | 43.13% | 36.72% | 37.04% | 35.44% | 33.33% | 32.10% | 33.33% | 29.03% | 29.55% | 31.58% | 31.43% | 21.43% | 9.09% | 0.00% |
| Operating Income | -272.08M | -30.50M | -20.37M | -5.30M | -4.90M | 9.78M | 2.18M | 16.31M | 16.32M | 15.86M | 11.79M | 13.10M | 12.48M | 9.86M | 7.37M | 7.61M | 7.06M | 5.66M | 4.11M | 3.48M | 3.25M | 3.19M | 2.94M | 2.81M | 2.85M | 3.10M | 2.80M | 2.50M | 2.40M | 1.90M | 1.60M | 1.30M | 1.20M | 900.00K | 500.00K | 100.00K | 0.00 |
| Operating Income Ratio | -125.85% | -13.92% | -11.05% | -3.96% | -4.16% | 9.48% | 2.27% | 17.42% | 19.28% | 22.24% | 22.35% | 28.22% | 31.49% | 30.05% | 33.60% | 35.33% | 36.10% | 32.82% | 35.48% | 34.61% | 35.60% | 35.09% | 32.53% | 30.84% | 32.87% | 38.27% | 35.44% | 32.05% | 29.63% | 28.79% | 25.81% | 29.55% | 31.58% | 25.71% | 17.86% | 9.09% | 0.00% |
| Total Other Income/Expenses | -3.57M | -3.71M | -1.13M | -10.06M | -4.06M | -1.16M | -1.88M | -2.02M | -768.00K | -517.00K | 1.32M | -126.00K | -146.00K | -113.00K | 36.00K | 86.00K | 195.00K | 130.00K | 193.00K | 98.00K | 50.00K | 55.16K | 78.51K | 70.96K | 243.83K | 100.00K | 400.00K | 100.00K | 0.00 | -100.00K | -100.00K | 0.00 | 100.00K | 100.00K | 0.00 | 100.00K | 0.00 |
| Income Before Tax | -275.65M | -389.00K | 3.57M | 2.30M | 3.43M | 8.62M | 301.00K | 14.30M | 15.56M | 15.35M | 13.10M | 12.98M | 12.33M | 9.75M | 7.40M | 7.69M | 7.26M | 5.79M | 4.30M | 3.57M | 3.30M | 3.24M | 3.02M | 2.88M | 3.09M | 3.20M | 3.20M | 2.60M | 2.40M | 1.80M | 1.50M | 1.30M | 1.30M | 1.00M | 0.00 | 200.00K | 0.00 |
| Income Before Tax Ratio | -127.50% | -0.18% | 1.94% | 1.72% | 2.92% | 8.36% | 0.31% | 15.26% | 18.37% | 21.52% | 24.85% | 27.95% | 31.13% | 29.71% | 33.76% | 35.73% | 37.10% | 33.57% | 37.15% | 35.58% | 36.15% | 35.69% | 33.40% | 31.62% | 35.69% | 39.51% | 40.51% | 33.33% | 29.63% | 27.27% | 24.19% | 29.55% | 34.21% | 28.57% | 0.00% | 18.18% | 0.00% |
| Income Tax Expense | -21.40M | -1.32M | 1.70M | -971.00K | 2.08M | 1.14M | 3.26M | 3.11M | 4.39M | 5.76M | 4.10M | 4.53M | 4.41M | 3.57M | 2.64M | 2.90M | 2.65M | 1.83M | 1.50M | 1.26M | 1.17M | 1.11M | 989.66K | 1.05M | 982.46K | 1.10M | 1.10M | 900.00K | 800.00K | 600.00K | 500.00K | 400.00K | 400.00K | 100.00K | 100.00K | 100.00K | 0.00 |
| Net Income | -254.25M | 930.00K | 1.87M | 3.27M | 1.35M | 7.48M | -2.96M | 11.18M | 11.17M | 9.58M | 9.00M | 8.45M | 7.92M | 6.18M | 4.77M | 4.79M | 4.61M | 3.96M | 2.81M | 2.31M | 2.13M | 2.13M | 2.03M | 1.83M | 2.11M | 2.10M | 2.10M | 1.70M | 1.60M | 1.20M | 1.00M | 900.00K | 900.00K | 900.00K | 400.00K | 100.00K | 0.00 |
| Net Income Ratio | -117.60% | 0.42% | 1.01% | 2.44% | 1.15% | 7.26% | -3.08% | 11.94% | 13.19% | 13.43% | 17.07% | 18.20% | 19.99% | 18.84% | 21.75% | 22.24% | 23.57% | 22.96% | 24.22% | 23.03% | 23.34% | 23.42% | 22.46% | 20.13% | 24.34% | 25.93% | 26.58% | 21.79% | 19.75% | 18.18% | 16.13% | 20.45% | 23.68% | 25.71% | 14.29% | 9.09% | 0.00% |
| EPS | -47.20 | 0.17 | 0.36 | 0.66 | 0.32 | 1.95 | -0.79 | 3.04 | 3.10 | 2.72 | 2.61 | 2.52 | 2.41 | 1.91 | 1.49 | 1.51 | 1.46 | 1.25 | 0.94 | 0.76 | 0.70 | 0.66 | 0.60 | 0.59 | 0.55 | 0.51 | 0.48 | 0.39 | 0.29 | 0.29 | 0.23 | 0.21 | 0.21 | 0.20 | 0.10 | 0.04 | 0.01 |
| EPS Diluted | -47.20 | 0.17 | 0.35 | 0.64 | 0.31 | 1.86 | -0.79 | 2.91 | 2.97 | 2.63 | 2.49 | 2.35 | 2.29 | 1.86 | 1.45 | 1.48 | 1.41 | 1.22 | 0.92 | 0.74 | 0.68 | 0.64 | 0.59 | 0.59 | 0.55 | 0.50 | 0.47 | 0.39 | 0.29 | 0.29 | 0.23 | 0.21 | 0.21 | 0.20 | 0.10 | 0.04 | 0.01 |
| Weighted Avg Shares Out | 5.39M | 5.32M | 5.21M | 4.98M | 4.20M | 3.84M | 3.75M | 3.68M | 3.61M | 3.52M | 3.45M | 3.36M | 3.29M | 3.23M | 3.19M | 3.18M | 3.17M | 3.16M | 2.99M | 3.06M | 3.05M | 3.23M | 3.41M | 3.69M | 3.82M | 4.14M | 4.30M | 4.47M | 4.33M | 4.14M | 4.35M | 4.29M | 4.29M | 4.50M | 4.00M | 2.50M | 3.48M |
| Weighted Avg Shares Out (Dil) | 5.39M | 5.36M | 5.34M | 5.12M | 4.37M | 4.03M | 3.77M | 3.84M | 3.76M | 3.65M | 3.61M | 3.59M | 3.46M | 3.33M | 3.29M | 3.24M | 3.28M | 3.23M | 3.05M | 3.14M | 3.14M | 3.30M | 3.45M | 3.72M | 3.84M | 4.17M | 4.40M | 4.47M | 4.33M | 4.14M | 4.35M | 4.29M | 4.29M | 4.50M | 4.00M | 2.50M | 3.48M |
Assenagon Asset Management S.A. Purchases New Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Assenagon Asset Management S.A. purchased a new stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,823 shares of the medical instruments...
Brokerages Anticipate Mesa Laboratories, Inc. (NASDAQ:MLAB) to Announce $2.03 EPS
Equities research analysts expect that Mesa Laboratories, Inc. (NASDAQ:MLAB) will announce earnings of $2.03 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Mesa Laboratories’ earnings, with estimates ranging from $1.93 to $2.13. Mesa...
Global Biological Indicators Market 2020 analysis with Key Players, Applications, Trends and Forecasts by 2024
Apr 20, 2020 (The Expresswire) -- The report outlines the competitive framework of the “Biological Indicators Market” industry detailing the SWOT analysis...
Mesa Laboratories, Inc. (NASDAQ:MLAB) Expected to Post Quarterly Sales of $34.50 Million
Wall Street analysts expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to announce $34.50 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Mesa Laboratories’ earnings. The lowest sales estimate is $34.00 million and...
Bank of America Corp DE Boosts Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Bank of America Corp DE grew its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 1.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,730 shares of the...
Goldman Sachs Group Inc. Trims Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Goldman Sachs Group Inc. lowered its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 79.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,216 shares of the medical instruments...
AQR Capital Management LLC Cuts Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)
AQR Capital Management LLC lessened its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 16.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,194 shares of the...
UBS Asset Management Americas Inc. Increases Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
UBS Asset Management Americas Inc. lifted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 36.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned...
Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
How far off is Mesa Laboratories, Inc. (NASDAQ:MLAB) from its intrinsic value? Using the most recent financial data...
Mesa Laboratories, Inc. (NASDAQ:MLAB) Receives Average Recommendation of "Buy" from Brokerages
Mesa Laboratories, Inc. (NASDAQ:MLAB) has received a consensus rating of “Buy” from the six analysts that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating, three have issued a buy rating and one...
Source: https://incomestatements.info
Category: Stock Reports